Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition in which susceptible individuals are at risk for the development of cutaneous leiomyomas, early onset multiple uterine leiomyomas and an aggressive form of type 2 papillary renal cell cancer. HLRCC is caused b...
Main Authors: | Menko, F, Maher, E, Schmidt, L, Middelton, L, Aittomäki, K, Tomlinson, I, Richard, S, Linehan, WM |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2014
|
Registos relacionados
-
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.
Por: Alam, N, et al.
Publicado em: (2003) -
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency
Por: Alam, N, et al.
Publicado em: (2003) -
Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome.
Por: Pollard, P, et al.
Publicado em: (2005) -
Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
Por: Alam, N, et al.
Publicado em: (2005) -
Exercise-induced ruptured renal tumour in a young patient with hereditary leiomyomata-associated renal cell carcinoma (HLRCC): a case report
Por: Mohamad Fairuz Mohamad Sharin, et al.
Publicado em: (2021)